Enza Capital

Enza Capital is a Nairobi-based multi-stage African venture firm deploying $1M-$5M cheques at Seed and Series A into high-growth technology businesses across East, West, and South Africa, including digital health and health IT software. The firm benefits from a balanced operating team across Nairobi, Lagos, and Cape Town, which gives portfolio companies practical access to regulatory navigation, talent, and customer development in the most important African markets. For founders, Enza is best understood as a regional generalist with selective health-tech conviction, useful as a domestic anchor or co-lead in syndicates with international and African partners. The right founder profile is an African operator building digital health, telemedicine, or B2B health software with paid customers, a credible plan to expand across at least two African markets, and ambitions to attract Series B follow-on from international leads. Founders running deep biotech, pre-product experiments, or single-country niche propositions are a poor fit. Entry path is via an Enza portfolio CEO, the AVCA African venture network, or warm introductions from co-investing funds (Norrsken22, EchoVC, FirstCheck, HealthCap, Ventures Platform). In the pitch, lead with multi-country unit economics in local currency with FX-aware forecasting, regulatory navigation in target geographies, and named customer logos. Caveats: African follow-on capital depth at Series B and beyond is structurally limited, so founders should plan international leads (US, UK, DFC, IFC) early and use Enza’s network to reach them. The fund’s AI focus is selective and commercial; AI-heavy founders should bring external technical validators. Confirm reserves and follow-on policy explicitly, and request a recent deal sheet to verify health-specific pacing for the current vintage.